CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset

被引:24
作者
Patti, Francesco [1 ]
Fiore, Maria [2 ]
Chisari, Clara G. [1 ]
D'Amico, Emanuele [1 ]
Lo Fermo, Salvatore [1 ]
Toscano, Simona [1 ]
Copat, Chiara [2 ]
Ferrante, Margherita [2 ]
Zappia, Mario [1 ]
机构
[1] Univ Catania, Dept Med & Surg Sci & Adv Technol GF Ingrassia, Sect Neurosci, I-95123 Catania, Italy
[2] Univ Catania, Dept Med & Surg Sci & Adv Technol GF Ingrassia, Environm & Food Hyg Lab LIAA, I-95123 Catania, Italy
关键词
Amyotrophic lateral sclerosis; Neurotoxic metals; Cerebrospinal fluids; Spinal onset; Bulbar onset; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; BLOOD-PLASMA; LEAD; EPIDEMIOLOGY; RISK; MANGANESE; SOD1; ALS; ASSOCIATION;
D O I
10.1016/j.envres.2020.109820
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Introduction: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder of the central nervous system (CNS) that causes progressive and irreversible damage in motor neurons. Different causal hypotheses include genetic, viral, traumatic and environmental mechanisms, such as exposure to heavy metals. The aim of this study was to compare metal/metalloid levels in cerebro-spinal fluid of ALS subtypes (spinal vs bulbar clinical onset). Material and methods: This observational study consecutively screened all ALS patients referring to the Neurology Clinic of the University of Catania (Italy). Inductively coupled plasma mass spectrometry (ICP-MS) was used to quantify magnesium (Mg), cuprum (Cu), selenium (Se), iron (Fe), manganese (Mn), vanadium (V), zinc (Zn), alluminium (Al), arsenic (As), cobalt (Co), nickel (Ni), mercury (Hg), lead (Pb), cadmium (Cd) and palladium (Pd) levels. Results: Thirty-seven patients were enrolled (62.2% females), median age of 65 years (IQR: 59-71 years). Thirty-one (83.8%) patients had a spinal onset and 6 (16.2%) a bulbar onset. Se and As levels were higher compared to the reference values (RV) both in spinal and bulbar onset, while Cu was higher than RV only in bulbar onset. Moreover, Cu (129.8 mu g/L vs 29.8 mu g/L), Fe (54.5 mu g/L vs 33.3 mu g/L), Mn (3.4 mu g/L vs 1.8 Zn (46.1 mu g/L vs 35.7 mu g/L), Al (12.2 mu g/L vs 6.7 mu g/L), Ni (2.80 mu g/L vs 1.40 mu g/L), and Pb (0.60 mu g/L vs 0.30 mu g/L) levels were higher in bulbar than in spinal onset, conversely As was slightly higher in spinal than in bulbar onset (1.40 mu g/L vs 1.10 mu g/L). Overall, Cu (129 mu g/L vs 31 mu g/L), Fe (92.2 mu g/L vs 32.9 mu g/L), Mn (3.35 mu g/L vs 1.80 Zn (56.5 mu g/L vs 35.2 mu g/L), Al (14.45 mu g/L vs 6.70 mu g/L), and Cd (0.40 mu g/L vs 0.08 mu g/L) levels were higher in patients with disease duration less than 19 months. Conclusion: Our results supported the hypothesis that metals/metalloids with neurotoxic effects could be involved in the etiology of ALS, showing higher levels of Cu, Se and As. Relevant differences in Cu and Mn levels were found between bulbar and spinal onset patients.
引用
收藏
页数:8
相关论文
共 65 条
[1]   Copper mediated neurological disorder: Visions into amyotrophic lateral sclerosis, Alzheimer and Menkes disease [J].
Ahuja, Anami ;
Dev, Kapil ;
Tanwar, Ranjeet S. ;
Selwal, Krishan K. ;
Tyagi, Pankaj K. .
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2015, 29 :11-23
[2]   Genetic and epigenetic studies of amyotrophic lateral sclerosis [J].
Al-Chalabi, Ammar ;
Kwak, Shin ;
Mehler, Mark ;
Rouleau, Guy ;
Siddique, Teepu ;
Strong, Michael ;
Leigh, Peter Nigel .
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2013, 14 :44-52
[3]  
Alimonti A., 2010, BIOMONITORAGGIO POPO
[4]   A REVIEW OF AXONAL-TRANSPORT OF METALS [J].
ARVIDSON, B .
TOXICOLOGY, 1994, 88 (1-3) :1-14
[5]   Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS [J].
Barbeito, Ana G. ;
Martinez-Palma, Laura ;
Vargas, Marcelo R. ;
Pehar, Mariana ;
Manay, Nelly ;
Beckman, Joseph S. ;
Barbeito, Luis ;
Cassina, Patricia .
NEUROBIOLOGY OF DISEASE, 2010, 37 (03) :574-580
[6]   Association between divalent metal transport 1 encoding gene (SLC11A2) and disease duration in amyotrophic lateral sclerosis [J].
Blasco, Helene ;
Vourc'h, Patrick ;
Nadjar, Yann ;
Ribourtout, Benedicte ;
Gordon, Paul H. ;
Guettard, Yves-Olivier ;
Camu, William ;
Praline, Julien ;
Meininger, Vincent ;
Andres, Christian R. ;
Corcia, Philippe .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 303 (1-2) :124-127
[7]   Amyotrophic lateral sclerosis spatial epidemiology in the Mount Etna region, Italy [J].
Boumediene, F. ;
Vasta, R. ;
Rascuna, C. ;
Lo Fermo, S. ;
Volanti, P. ;
Marziolo, R. ;
Patti, F. ;
Ferrante, M. ;
Preux, P. M. ;
Marin, B. ;
Giammanco, S. ;
Zappia, M. ;
Nicoletti, A. .
EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (11) :E90-E91
[8]   Role of manganese in neurodegenerative diseases [J].
Bowman, Aaron B. ;
Kwakye, Gunnar F. ;
Hernandez, Elena Herrero ;
Aschner, Michael .
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2011, 25 (04) :191-203
[9]   Amyotrophic lateral sclerosis and environmental factors [J].
Bozzoni, Virginia ;
Pansarasa, Orietta ;
Diamanti, Luca ;
Nosari, Guido ;
Cereda, Cristina ;
Ceroni, Mauro .
FUNCTIONAL NEUROLOGY, 2016, 31 (01) :7-19
[10]   El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis [J].
Brooks, BR ;
Miller, RG ;
Swash, M ;
Munsat, TL .
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2000, 1 (05) :293-299